Monday, December 23, 2024
spot_img
HomeHormones & Pharmacological AgentsClinical Research AbstractsAntibodies Protect Against COVID-19 Reinfection, According to NIH

Antibodies Protect Against COVID-19 Reinfection, According to NIH

Researchers looked at more than 3 million people who had an antibody test for SARS-CoV-2. SARS-CoV-2 is the virus that causes COVID-19.

Image: A cell from a patient (purple) infected with SARS-CoV-2 (blue) Image Credit: NIAID 

They found that about 11% of people had SARS-CoV-2 antibodies. More than 88% had a negative test. And less than 1% of tests were inconclusive.

The scientists looked at who came down with COVID-19 after the test. They analyzed up to 30 days, 31–60 days, 61–90 days, and more than 90 days after.

About 3% to 4% of people with negative antibody tests got COVID-19 in each time period. But those who had antibodies were less likely to have COVID-19 as time went on. Only 0.3% of the people with antibodies had a positive COVID-19 test more than 90 days after. Those without antibodies were 10 times more likely to get the disease.

The findings suggest that people who have a positive result from an antibody test may be at lower risk for future infection with SARS-CoV-2.

NIH’s Dr. Lynn Penberthy, who led the research team, explains that more questions still need to be answered. “We are nevertheless encouraged by this early finding,” she says.

This article is a direct reprint from the original posted on NIH News In Health

Image: A cell from a patient (purple) infected with SARS-CoV-2 (blue) Image Credit: NIAID 

As with anything you read on the internet, this article should not be construed as medical advice; please talk to your doctor or primary care provider before making any changes to your wellness routine.

Materials provided by:

Content may be edited for style and length

https://newsinhealth.nih.gov/2021/04/antibodies-protect-against-covid-19-reinfection

https://pubmed.ncbi.nlm.nih.gov/33625463/

RELATED ARTICLES

Most Popular